Brain Frailty Rather than Age Alone Mediates the Lack of Benefit for Endovascular Thrombectomy in the Elderly Population of the RESILIENT Trial
- 10 May 2026
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 100 (2) , 361-369
Abstract
Objective: The objective of this study was to determine whether baseline computed tomography (CT) markers of cerebral small vessel disease (cSVD), as a surrogate of brain frailty, explain the association between age and functional outcome, potentially accounting for the reduced apparent benefit of mechanical thrombectomy (MT) in elderly patients in the RESILIENT trial. Methods: RESILIENT was a multicenter, prospective, randomized, open‐label trial with blinded outcome assessment conducted in Brazil. Patients with anterior circulation large‐vessel occlusion stroke were randomized to MT plus guideline‐based care or guideline‐based care alone, including intravenous alteplase when eligible. A vascular neurologist blinded to clinical data evaluated baseline CT scans for cSVD markers (leukoaraiosis, lacunes, and atrophy) to derive a composite cSVD score. Multivariable logistic regression identified independent predictors of good functional outcome (modified Rankin Scale [mRS] = 0–2 at 90 days). Treatment effects were assessed across subgroups defined by age (p < 0.01). No benefit was observed in older patients or in those with cSVD > 1. Mediation analysis showed that cSVD significantly mediated the association between age and outcome (average causal mediation effect [ACME] = –0.003, 95% CI = –0.005 to 0.00, p = 0.010). Interpretation: Baseline CT markers of cSVD were independently associated with poorer outcomes and mediated the association between age and functional outcome in the RESILIENT trial, potentially explaining the lack of MT efficacy in older patients. ANN NEUROL 2026Keywords
This publication has 33 references indexed in Scilit:
- Is it time to develop neurocritical care education in Brazil? Analysis of the Brazilian national survey on education in neurocritical careArquivos de Neuro-Psiquiatria, 2026
- Deep learning and machine learning for differentiation between contrast extravasation and hemorrhagic transformation in post-thrombectomy stroke CTJournal Of Neuroradiology, 2026
- Systemic Microvasculature Frailty: Brain frailty score predicts contrast-associated acute kidney injury after thrombectomy for strokeClinical Neurology and Neurosurgery, 2026
- Spontaneous Intracranial Hemorrhage in Brazil: Trends, Seasonality, Pandemic Disruption, and Cost BurdenWorld Neurosurgery, 2026
- Reperfusion therapy for acute ischemic stroke: where are we in 2023?Arquivos de Neuro-Psiquiatria, 2023
- Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trialThe Lancet, 2023
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income CountriesNew England Journal of Medicine, 2014